Creon DR 12,000 unit capsule UU 100S
Ended Awarded Last action
- Contract number
- SPE2DR26F9LQ0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,032
Award facts
- Contract value 100% obligated
- $7,031.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 16, 2026, for the supply of 12,000 unit capsules of Creon DR 100s, a pancreatic enzyme replacement medication used to treat pancreatic insufficiency. The contract is valued at $7,031.95 with a firm fixed-price structure and an ultimate completion date of January 20, 2026. This delivery order was awarded on a fully competitive basis with no set-aside designation and represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.99 million through December 31, 2031. The work will be performed at the contractor's location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, supplying medications across multiple therapeutic domains through the DLA Medical Supply Chain. This particular delivery order for Creon capsules supports ongoing pharmaceutical supply needs for military treatment facilities and healthcare programs. The parent company's substantial IDC with DLA enables flexible ordering of pharmaceutical products, medical supplies, vaccines, and specialized medical commodities to support global military healthcare operations, demonstrating the contractor's significant role in the federal pharmaceutical procurement landscape.
Quick answers
Who was awarded contract SPE2DR26F9LQ0?
SPE2DR26F9LQ0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26F9LQ0 worth?
The government has obligated $7,032 on SPE2DR26F9LQ0.
Is contract SPE2DR26F9LQ0 an order under another contract?
Yes. SPE2DR26F9LQ0 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9LQ0 competed?
The extent of competition for SPE2DR26F9LQ0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award